The authors found that treatment with apixaban was associated with a numerically higher rate of major bleeding; however, the difference did not reach statistical significance ( P = 0.1). 35 Another study, which used data from 4 U.S.
← all excerpts
Oral Anticoagulants and Risk of Bleeding and Death in Cancer-Associated Venous Thromboembolism.
1
0.1000
0.1000